… tuberculosis (MDR-TB; defined as strains of M. tuberculosis resistant to at least isoniazid
and rifampicin, the two most powerful anti-TB drugs), have recently received heightened …

… treat tuberculosis (TB), and particularly multidrug resistant TB … of HIV and drug-resistant TB.
Better understanding on the … the pathogenicity of drug resistant strains. The effectiveness of …

… -tuberculosis drugs (ie, isoniazid and rifampicin). Therapeutic regimens based on second-
and third-line anti-tuberculosis … in 2012 the multi-drug resistant tuberculosis incidence ranged …

… of recent infections are likely to be multi-drug resistant, resulting in higher rates of MDR-TB …
with drug resistant isolates, and thus be infected or re-infected with a resistant isolate. The …

Drug-resistant tuberculosis, especially that with resistance to rifampicin (RR-TB), has become
one of the main obstacles to achieving the dream of eradicating tuberculosis. Furthermore, …

… Data on the prevalence of drug resistant tuberculosis are currently presented … resistant to
anti-tuberculosis drugs. This article discusses global data on multi-drug resistant tuberculosis …

… (TB), merits being one of the highest priority pathogens on this list since drug-resistant TB
(… current cure rate for multi-drug-resistant TB (MDR-TB) and extensively drug-resistant TB (XDR-…

United Kingdom (UK) guidelines recommend at least 18 months treatment for patients with
multidrug-resistant tuberculosis (MDR-TB). Prior to 2008, data on treatment outcome were …

… All patients had multi–drug resistant tuberculosis and had a minimum of 3 months of …
therapy for the treatment of multi–drug resistant Mycobacterium tuberculosis. In the setting of …

… resistance especially multi-drug resistant tuberculosis (MDR-… Effective treatment of multi-drug
resistant tuberculosis cases … drug resistant cases especially multi-drug resistant tuberculosis…